SuperCrowd
Progress update · Form C-U
A progress update — the company is reporting how its raise is going (often that it hit its target).
SafeRx Pharmaceuticals Inc.
saferxpharmaceuticals.com · DE · Filed May 2, 2022
SafeRx Pharmaceuticals Inc. filed a Form C-U — progress update — with the SEC on May 2, 2022. The Regulation Crowdfunding offering seeks $25,000, up to a maximum of $5,000,000 on Dalmore. Investors receive: Common Stock at $2.21. The offering closes 04-30-2022.
| Target raise | $25,000 |
|---|---|
| Maximum raise | $5,000,000 |
| Security | Common Stock @ $2.21 |
| Closes | 04-30-2022 |
| Portal | Dalmore |
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.